MedPath

Recombinant Cytokine Gene Derived Protein

Generic Name
Recombinant Cytokine Gene Derived Protein

Overview

No overview information available.

Indication

用于治疗HBeAg阳性的慢性乙型肝炎。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2021/08/24
Phase 3
UNKNOWN
Beijing 302 Hospital
2014/02/21
Phase 2
UNKNOWN
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Recombinant Cytokine Gene Derived Protein Injection
国药准字S20180002
生物制品
注射剂
12/12/2023

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.